Inflammatory Myopathies

• CLINICAL_TRIALS research · 2026-02-25
  Clinical Trial Update: Inspiratory Muscle Training in Patients With Inflammatory Myopathy [NA]

  Clinical trial assessing inspiratory muscle training in patients with inflammatory myopathies; recruitment is currently ongoing.

• CLINICAL_TRIALS research · 2025-12-03
  Clinical Trial Update: Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients

  A recruiting clinical trial examining interferon signature differences between cancer patients treated with anti-CTLA-4 or anti-PD-1/PD-L1 t…

• CLINICAL_TRIALS research · 2025-09-23
  Clinical Trial Update: Mass Spectrometry-based Immune Profiling in Autoimmune Diseases

  A clinical trial from Peking University People's Hospital evaluating mass spectrometry-based immune profiling across autoimmune diseases; th…

• CLINICAL_TRIALS research · 2025-08-20
  Clinical Trial Update: Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases [Phase 1, Phase 2]

  This clinical trial update describes a phase 1/2 study evaluating universal CD19-targeting CAR-γδT cells for refractory autoimmune diseases,…

• CLINICAL_TRIALS research · 2025-02-12
  Clinical Trial Update: Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined with Immunosuppressants in the Treatment of Refractory Autoimmune Diseases [Phase 1, Phase 2]

  Phase 1/2 clinical trial evaluating safety and efficacy of universal CD19 CAR-T cells (UWD-CD19) with immunosuppressants for refractory auto…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2025-02-11
  Clinical Trial Update: A Study of Imvotamab in Active, Refractory Idiopathic Inflammatory Myopathies [Phase 1]

  A Phase 1 study of Imvotamab in active, refractory idiopathic inflammatory myopathies has been terminated (Status: TERMINATED).